Jon Soderstrom, Ph.D., is the Managing Director of the Office of Cooperative Research at Yale University responsible for commercializing inventions resulting from Yale’s scientific research including patent license agreements, strategic corporate partnerships and the formation of new business ventures. Since joining the Office in 1996, he has helped form more than 25 new ventures including Molecular Staging (acquired by Qiagen), Achillion Pharmaceuticals (NASQ: ACHN), Protometrix (acquired by Invitrogen), Iconic Therapeutics, HistoRx (acquired by Genoptix), Kolltan Pharmaceuticals (acquired by Celldex), Arvinas (NASDAQ: ARVN) and Artizan Biosciences. Collectively, these companies have raised over $500 million in professional venture capital. Dr. Soderstrom was a founding board member and past president of the Association of Federal Technology Transfer Executives as well as a member of the Licensing Executive Society and Association of University Technology Managers (President 2008; VP Public Policy). He is frequently asked to lecture on various aspects of the technology commercialization and economic development both within the United States and abroad. Dr. Soderstrom has testified before Congress on technology transfer issues and served as an expert witness in patent infringement/contract litigation. He received his Ph.D. from Northwestern University and his B.A. from Hope College.